GOSS Bathi mangsa ngarep Gossamer Bio Inc
The net profit forecast visualizes the potential of Gossamer Bio, Inc. (GOSS) within the cardiovascular pathology niche, where therapy exclusivity will ensure high drug pricing. captures the magnitude of this parameter. Growth is based on the implementation of inhaled seralutinib for the treatment of pulmonary hypertension. Additionally, Gossamer Bio, Inc. (GOSS) is implementing AI algorithms and automating biomaterial processing in its laboratories.
Rincian analitis perusahaan Gossamer Bio, Inc.
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- informasi kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Gossamer Bio, Inc.|GOSS - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Gossamer Corp|GOSS - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Gossamer Bio|GOSS - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Gossamer Bio|Rasio cepet gossamerbio.com
- informasi bathi lan kelipatan valuasi:
GOSS - Bathi resik taunan|Bathi sing dikarepake Gossamer Bio, Inc.|GOSS - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Gossamer Bio|GOSS - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Gossamer Bio|GOSS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Gossamer Bio|GOSS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan gossamerbio.com|GOSS - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Gossamer Bio, Inc.
- rincian pendapatan lan dodolan:
Analisis dhasar perusahaan:GOSS, Gossamer Bio, Inc.
The efficiency of complex biomaterial logistics during immunological drug trials at Gossamer Bio, Inc. (GOSS) directly determines research accuracy and the future commercial value of the therapy. Analyzing the prospective profit chart, an investor can observe the discounted earnings per share in a daily cross-section, allowing for the timely detection of systemic business degradation or the confirmation of capital stability via an upward trend in the metric.
Perusahaan pesaing
ARGX (argenx SE) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep biontech.de|Bathi mangsa ngarep ABVX (Abivax Corp)|ADMA (ADMA Biologics Inc) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep PTGX (Protagonist Therapeutics Inc)|Prakiraan bathi perusahaan Immunovant Therapeutics (IMVT)|KNSA - Bathi sing dikarepake|grifols.com (GRFS) - Bathi mangsa ngarep|Adaptive Biotechnologies Corporation (ADPT) - Bathi sing dikarepake|Bathi mangsa ngarep Celldex Therapeutics Inc|Bathi mangsa ngarep AUPH|Proyeksi bathi mangsa ngarep BioCryst Corp|Bathi sing dikarepake Vera Therapeutics, Inc. (VERA)|dianthustx.com - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep PHVS (Pharvaris)|AbCellera Corp (ABCL) - Bathi resik sing dikarepake|Tourmaline Corp - Proyeksi bathi mangsa ngarep|Proyeksi bathi resik Precigen Corp (PGEN)|Pharming Group N.V. (PHAR) - Bathi sing dikarepake|Bathi resik sing dikarepake nektar.com (NKTR)|Bathi sing dikarepake Upstream Bio|Zenas Bio (ZBIO) - Prakiraan bathi perusahaan|Bathi sing dikarepake Immunome Corp (IMNM)|Prakiraan bathi perusahaan KalVista Corp|Proyeksi bathi mangsa ngarep SEPN (Septerna Inc)|Proyeksi bathi mangsa ngarep pieris.com PVLA|SVRA - Bathi sing dikarepake|Rigel Pharma (RIGL) - Bathi mangsa ngarep|ANAB: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Astria Corp (ATXS)|Bathi sing dikarepake enGene Holdings Inc.|RAPT: Penghasilan resik sing dikarepake|Bathi mangsa ngarep JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep KYTX (Kyverna)|Tiziana Life Sciences, Ltd. - Bathi sing dikarepake|Cabaletta Bio, Inc. - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan ventyxbio.com VTYX|Theratechnologies (THTX) - Bathi sing dikarepake|Bathi resik sing dikarepake Avalo Therapeutics, Inc. (AVTX)|Bathi mangsa ngarep ELDN|AGEN: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CLYM|Prakiraan bathi perusahaan zurabio.com|Bathi sing dikarepake aTyr Pharma ATYR|ADAG: Prakiraan bathi resik|Ikena Oncology, Inc. - Proyeksi bathi mangsa ngarep|Shattuck Labs, Inc. (STTK) - Bathi mangsa ngarep|EQ (equilliumbio.com) - Bathi mangsa ngarep|CNTB - Prakiraan bathi perusahaan|IMUX (Immunic Therapeutics) - Proyeksi bathi mangsa ngarep|ATRA - Proyeksi bathi resik|Bathi sing dikarepake InflaRx N.V. (IFRX)|XFOR - Bathi resik sing dikarepake|Bathi sing dikarepake Adicet Bio, Inc. ACET|Prakiraan bathi perusahaan Celularity Inc (CELU)|INMB - Bathi sing dikarepake|Prakiraan bathi perusahaan Barinthus Biotherapeutics PLC BRNS|Kezar Life Sciences, Inc (KZR) - Bathi sing dikarepake|Bathi forward SABS (SAB Biotherapeutics Inc)|AKTX (Akari Therapeutics) - Proyeksi bathi mangsa ngarep|ENLV: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep QTTB|Proyeksi bathi mangsa ngarep GeoVax Labs (GOVX)|Bathi sing dikarepake Edesa EDSA|Penghasilan resik sing dikarepake IBIO|CARM - Bathi sing dikarepake|xtlbio.com (XTLB) - Bathi mangsa ngarep|BOLT: Proyeksi bathi mangsa ngarep|HCW Biologics (HCWB) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep APVO|AIM: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ADTX|Prakiraan bathi perusahaan gribio.com|Bathi sing dikarepake XORTX Therapeutics XRTX|HIND - Bathi mangsa ngarep|REVB - Bathi sing dikarepake|Indaptus Corp (INDP) - Bathi mangsa ngarep|SCNI (Scinai Immunotherapeutics) - Bathi mangsa ngarep|CalciMedica (CALI) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Affimed NV|Prakiraan bathi resik ALLK (Allakos Therapeutics)|Proyeksi bathi mangsa ngarep HOOK|IGMS - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ITOS (iTeos Therapeutics)|Proyeksi bathi resik oceanbiomedical.com|TCBP - Bathi sing dikarepake|Bathi resik sing dikarepake Third Harmonic Bio Inc.
